Wirelessly observed therapy compared to directly observed therapy to confirm and support tuberculosis treatment adherence: A randomized controlled trial

Author:

Browne Sara H.ORCID,Umlauf Anya,Tucker Amanda J.,Low JulieORCID,Moser Kathleen,Gonzalez Garcia Jonathan,Peloquin Charles A.ORCID,Blaschke Terrence,Vaida Florin,Benson Constance A.

Funder

Alliance Healthcare Foundation

National Institute of Mental Health

Specialists in Global Health

Publisher

Public Library of Science (PLoS)

Subject

General Medicine

Reference42 articles.

1. Global TB Report WHO. 2018 [cited 2018 August 28]. Available from: http://www.who.int/tb/publications/global_report/en/.

2. Development, roll-out and impact of Xpert MTB/RIF for tuberculosis: what lessons have we learnt and how can we do better?;H Albert;Eur Respir J,2016

3. Rapid Communication: Key changes to treatment of multidrug- and rifampicin-resistant tuberculosis (MDR/RR-TB). 2018. [cited 2018 Aug]. Available from: [http://www.who.int/tb/publications/2018/rapid_communications_MDR/en/.

4. New anti-tuberculosis drugs and regimens: 2015 update;L D'Ambrosio;ERJ Open Res,2015

5. Adherence interventions and outcomes of tuberculosis treatment: A systematic review and meta-analysis of trials and observational studies;N Alipanah;PLoS Med,2018

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3